EUVIMEDEUVIMED entdecken
Crossref

Glycyrrhetinic acid loaded in milk-derived extracellular vesicles for inhalation therapy of idiopathic pulmonary fibrosis

Bo Ran, Xiaohong Ren, Xueyuan Lin, Yupu Teng, Fangyuan Xin, Wuzhen Ma, Xiangyu Zhao, Mingwei Li, Jinghuang Wang, Caifen Wang, Lixin Sun, Jiwen Zhang

Journal of Controlled Release · 2024-06 · 370 · 811-820

DOI: 10.1016/j.jconrel.2024.05.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-06. Verfasst von Bo Ran und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shenyang Pharmaceutiacal University, Shenyang 110016, China; Center for Drug Delivery System, Shanghai Institute of Materia Medica, Chinese Academy o…. Hauptthemen laut MEDLINE: Glycyrrhetinic Acid, Idiopathic Pulmonary Fibrosis, Extracellular Vesicles, Milk. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and life-threatening lung disease for which treatment options are limited. Glycyrrhetinic acid (GA) is a triterpenoid with multiple biological effects, such as anti-inflammatory and anti-fibrotic properties. Herein, inhalable milk-derived extracellular vesicles (mEVs) encapsulating GA (mEVs@GA) were screened and evaluated for IPF treatment. The results indicated that the loading efficiency of GA in mEVs@GA was 8.65%. Therapeutic effects of inhalable mEVs@GA were investigated in vitro and in vivo. The mEVs@GA demonstrated superior anti-inflammatory effects on LPS-stimulated MHS cells. Furthermore, repeated noninvasive inhalation delivery of mEVs@GA in bleomycin-induced IPF mice could decrease the levels of transforming growth factors β1 (TGF-β1), Smad3 and inflammatory cytokines IL-6, IL-1β and TNF-α. The mEVs@GA effectively diminished the development of fibrosis and improved pulmonary function in the IPF mice model at a quarter of the dose compared with the pirfenidone oral administration group. Additionally, compared to pirfenidone-loaded mEVs, mEVs@GA demonstrated superior efficacy at the same drug concentration in the pharmacodynamic study. Overall, inhaled mEVs@GA have the potential to serve as an effective therapeutic option in the treatment of IPF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycyrrhetinic AcidIdiopathic Pulmonary FibrosisExtracellular VesiclesMilkMice, Inbred C57BLCytokinesAnimalsAdministration, InhalationAnti-Inflammatory AgentsBleomycinMaleLungMiceHumansCell LineDrug CarriersSmad3 Protein

Stichwörter der Autor:innen

Glycyrrhizic acidIdiopathic pulmonary fibrosisInhalation administrationMilk-derived extracellular vesiclesPifenidone

Substanzen

Glycyrrhetinic AcidCytokinesAnti-Inflammatory AgentsBleomycinDrug CarriersSmad3 Protein

Autor:innen und Institutionen

  • Shenyang Pharmaceutiacal University, Shenyang 110016, China; Center for Drug Delivery System, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201210, China; Yangtze Delta Drug Advanced Resear…
  • Center for Drug Delivery System, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201210, China; State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and T…
  • Center for Drug Delivery System, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201210, China; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Center for Drug Delivery System, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201210, China; Yangtze Delta Drug Advanced Research Institute, Nantong 226126, China.
  • Shenyang Pharmaceutiacal University, Shenyang 110016, China; Center for Drug Delivery System, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201210, China.
  • Shenyang Pharmaceutiacal University, Shenyang 110016, China. Electronic address: slx04@163.com.

Zitieren

APA

Ran, B., Ren, X., Lin, X., Teng, Y., Xin, F., Ma, W., Zhao, X., Li, M., Wang, J., Wang, C., Sun, L., & Zhang, J. (2024). Glycyrrhetinic acid loaded in milk-derived extracellular vesicles for inhalation therapy of idiopathic pulmonary fibrosis. Journal of Controlled Release, 370, 811-820. https://doi.org/10.1016/j.jconrel.2024.05.024

Vancouver

Ran B, Ren X, Lin X, Teng Y, Xin F, Ma W, et al. Glycyrrhetinic acid loaded in milk-derived extracellular vesicles for inhalation therapy of idiopathic pulmonary fibrosis. Journal of Controlled Release. 2024;370:811-820. doi:10.1016/j.jconrel.2024.05.024

BibTeX
@article{Ran2024,
  author = {Ran, Bo and Ren, Xiaohong and Lin, Xueyuan and Teng, Yupu and Xin, Fangyuan and Ma, Wuzhen and Zhao, Xiangyu and Li, Mingwei and Wang, Jinghuang and Wang, Caifen and Sun, Lixin and Zhang, Jiwen},
  title = {Glycyrrhetinic acid loaded in milk-derived extracellular vesicles for inhalation therapy of idiopathic pulmonary fibrosis},
  journal = {Journal of Controlled Release},
  year = {2024},
  volume = {370},
  pages = {811--820},
  doi = {10.1016/j.jconrel.2024.05.024}
}
Kostenlos starten →